Could a diabetes drug help liver transplant patients control blood sugar and weight?
NCT ID NCT05195944
First seen Apr 06, 2026 · Last updated May 16, 2026 · Updated 7 times
Summary
This study tests whether semaglutide (a once-daily pill) works better than sitagliptin (another diabetes drug) at controlling blood sugar and body weight in people who have had a liver transplant and have poorly controlled diabetes. About 58 adults who are at least 3 months post-transplant will take one of the two drugs for a set period. The goal is to see if semaglutide can improve diabetes management and weight without causing safety issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Toronto General Hospital
Toronto, Ontario, M5G 2N2, Canada
Conditions
Explore the condition pages connected to this study.